Abstract
Magnesium sulfate's reputation waxed as eclampsia's perniciousness waned. Since 1906, when eclampsia was first described, earlier diagnoses, better antihypertensive treatment, and improved intensive care have assured increasingly better results. The omission of control subjects assured that credit would accrue to magnesium sulfate, the treatment of choice. Moreover, because of its wide-spread use, physicians gained extensive experience with use of the drug, decreasing its complications and improving further its apparent beneficial effects. Dinsdale makes a gallant case for the use of magnesium sulfate in eclampsia, based in part on his own considerable knowledge and contributions to the understanding of other types of hypertensive encephalopathy, but he acknowledges that magnesium sulfate's usefulness has never been demonstrated in a controlled clinical trial. Kaplan and colleagues argue convincingly that there are better methods of treating both the hypertension and the seizures commonly associated with eclampsia. Until such time as we have a better grasp
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
